At the 23rd International Medical Instruments & Equipment (ChinaMed) Exhibition, March 25-27 in Beijing, Elekta (booth # 3A001) will showcase its comprehensive oncology solutions for managing cancer safely and effectively.Beijing China — Tuesday, March 22, 2011
“To serve its large population, China is making unprecedented healthcare investments, increasing the demand for new care capacity, particularly for patients with cancer,” says Ian Alexander, Executive Vice President of Elekta’s Asia Pacific Region. “Through acquisition and innovation, Elekta has a strong portfolio of solutions that supports the management of a patient's cancer care and we’re proud to participate in the effort to deliver advanced technology to more people in the region.”
During the exhibition, Elekta will introduce its 3D ultrasound technology, Clarity™, to the Chinese market. Prioritizing patient comfort and safety by exploiting a non-invasive, non-ionizing imaging modality, Clarity system solutions are available to provide image guidance for patients with cancer of the breast, prostate, gynecological, liver, bladder or head and neck cancer.
In addition, Elekta also will demonstrate:
According to Gilbert Wai, Managing Director for Elekta China, Elekta has become the market leader in China.
"Our history in the country dates back to 1982, and has resulted in a focused and strong organization, conducting a full range of business activities, such as R&D, engineering, manufacturing, sourcing, sales, marketing and clinical and technical services,” he says. “Elekta has truly evolved into a comprehensive solutions partner in China. We are dedicated to support the rapid growth in demand, not only in equipment, but also in clinical implementation and training services to improve access to high quality cancer treatment and management in China.”
ChinaMed, among the most influential exhibitions in Chinese medical instruments and equipment industry, is co-organized by the Health Department of General Logistics Department of Chinese People’s Liberation Army, China World Trade Center Co., Ltd., Hui Tong Xingye International Exhibition (Beijing) Co., Ltd. and Messe Düsseldorf (Shanghai) Co., Ltd. China Med expects more than 26,000 show attendees from 48 nations and regions.
*Clarity™, iViewC™ and Elekta Compact™ are not available for sale or distribution in all regions. Please contact your local Elekta representative or authorized distributor for further details.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37
Time zone: CET: Central European
Michelle Lee, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447
Time zone: EDT: Eastern Daylight Time